Controlled treatment of tissue and dynamic interaction with, and comparison of, tissue and/or treatment data

ABSTRACT

An interactive treatment mapping and planning system enables a user to more quickly, thoroughly, and efficiently aggregate fibroid and/or treatment information from a user and/or one or more sets of databases, construct a fibroid map providing a visual representation of the aggregated fibroid information, generate information from the aggregated information about the fibroid to be treated and/or treatment procedure, develop a treatment plan based on the fibroid and/or treatment procedure information, provide real-time information gathered from treatment devices during the treatment procedure, and allow the user to interact with the treatment data.

INCORPORATION BY REFERENCE

The present application is a continuation of International PatentApplication No. PCT/US2017/060674, filed on Nov. 8, 2017, which claimspriority benefit of U.S. Provisional Patent App. No. 62/421,119, filedNov. 11, 2016. Any and all applications for which a foreign or domesticpriority claim is identified in the Application Data Sheet as filed withthe present application are hereby incorporated by reference under 37C.F.R. § 1.57. Additionally, each of U.S. Pat. Nos. 8,088,072 and8,992,427 is incorporated herein by reference in their entirety so as toform a part of the present application.

TECHNICAL FIELD

The present disclosure relates generally to medical methods and systemsfor controlling the deployment of needles through the construction oftreatment maps. Embodiments of the present disclosure relate to systemsand techniques for providing a user interface for dynamic interactionswith fibroid data and treatment data. More specifically, embodiments ofthe present disclosure relate to user interfaces for dynamicallyproviding a visual representation of information generated byaggregating treatment data from one or more medical articles andgenerating information.

BACKGROUND

Current medical treatments of organs and tissues within a patient's bodyoften use a needle or other elongate body for delivery of energy,therapeutic agents or the like. Some methods use ultrasound imaging toobserve and identify a treatment target and predict and track theposition of the needle relative to the treatment target.

A treatment for uterine fibroids has recently been proposed which relieson the transvaginal or laparoscopic positioning of a treatment device inthe patient's uterus. A radiofrequency or other energy or therapeuticdelivery needle is deployed from the device into the fibroid, and energyand/or therapeutic substances are delivered in order to ablate or treatthe fibroid. To facilitate locating the fibroids and positioning theneedles within the fibroids, the device includes an ultrasonic imagingarray with an adjustable field of view in a generally forward or lateraldirection relative to an axial shaft which carries the needle. Theneedle is advanced from the shaft and across the field of view so thatthe needle can be visualized and directed into the tissue and thetargeted fibroid.

SUMMARY

The systems, methods, and devices described herein each have severalaspects, no single one of which is solely responsible for its desirableattributes. Without limiting the scope of this disclosure, severalnon-limiting features will now be described briefly.

Embodiments of the present disclosure relate to an interactive treatmentmapping and planning system and techniques for inputting and/orreceiving fibroid data, generating information from the fibroid and/ortreatment data, and displaying visual representations of the treatmentdata to enable a user to efficiently obtain information in aninteractive user interface. The system may include techniques forproviding real-time updates detailing ongoing treatment data. Disclosedherein are systems that advantageously provide highly efficient,intuitive, and rapid dynamic interaction with fibroid data and treatmentdata to enable the user to generate information about the treatmentprocedure. The systems may include interactive user interfaces that aredynamically updated to provide rapid comparison of multiple fibroids tobe treated. Further, treatment information may be automatically sorted,for example, in some embodiments, by the system according to attributesassociated with the treatment procedure and rules and/or preferences ofthe user.

Systems and methods are disclosed for providing a treatment mapping andplanning system. The system provides fibroid location on a userinterface. The user interface may comprise a map of the fibroids to betreated and/or treatment procedure information and activity at theindividual fibroid level. The user may select a fibroid to be treatedfrom the user interface, and the system may prompt the user to providethe system with information about the fibroid. Accordingly, a user mayuse the systems described herein to more quickly, thoroughly, andefficiently interact with multiple fibroid information and develop anefficient treatment plan based on the various fibroids to be treated.The features and advantages noted above, as well as others, arediscussed in further detail below.

In various embodiments, the system creates a representation of thefibroids to be treated, including for example, descriptions of thefibroids, fibroid locations, fibroid type (e.g., intramural, submucosal,subserosal, pedunculated submucosal, pedunculated subserosal), estimatedfibroid sizes, and other fibroid information.

In various embodiments, systems and methods are disclosed foraggregating fibroid and/or treatment data points, and generatinginformation about the treatment procedure. For example, the fibroidand/or treatment data points may comprise at least one of a fibroidlocation, a fibroid size, a fibroid treatment order, or other fibroidinformation.

In various embodiments, systems and methods are disclosed foraggregating fibroid and/or treatment data points from various datasources. For example, the various data sources may comprise at least oneof an input from a user, a user data source, or a third party datasource.

In various embodiments, the system provides color coded icons, includingorder of treatment and other information. The other information maycomprise estimated fibroid size, fibroid treatment status, and otherfibroid information. Warnings may alert the user to situations in whicha mapped fibroid has not been treated.

In various embodiments, system and methods are disclosed forcategorizing the fibroid to be treated based on aggregated fibroidinformation. The categories may be based on fibroid size, order oftreatment, fibroid location, fibroid prior treatment status, and otherfibroid information. The system may automatically identify a mappedfibroid as one with particular interest to the user based on thecategorization and provide the user with a visual representationindicating the fibroid's status. The user may then select and interactwith the fibroid.

In various embodiments, data from the treatment devices may be acquiredduring the treatment procedure. The treatment data may be automaticallyand dynamically processed interactively in response to user andtreatment device inputs, and the processed data is efficiently andcompactly presented to a user by the system. Thus, in some embodiments,the user interfaces described herein are more efficient as compared toprevious recording methods in which treatment data is not dynamicallyupdated and compactly and efficiently presented to the user in responseto use of the treatment devices.

The system may be configured and/or designed to generate user interfacedata useable for rendering the various interactive user interfacesdescribed. The user interface data may be used by the system, and/oranother computer system, device, and/or software program (for example, abrowser program) to render the interactive user interfaces. Theinteractive user interfaces may be displayed on, for example, electronicdisplays (including, for example, touch-enabled displays).

In various embodiments, systems and methods are disclosed for generatinga user interface including a fibroid map. The fibroid map may include avisual representation of information relating to a fibroid. For example,the visual representation may comprise a fibroid icon.

In various embodiments, systems and methods are disclosed foridentifying a fibroid using an imaging modality and generating a userinterface configured to provide knowledge relating to the identifiedfibroid.

In various embodiments, systems and methods are disclosed for acquiringdata from an imaging modality. For example the data may comprise atleast one of a position of the imaging modality, an orientation of theimagining modality, an insertion depth, an insertion angle, a fibroidlocation, a fibroid size, or other imagine modality information.

In various embodiments, systems and methods are disclosed foraggregating information about a treatment device via a sensor. Forexample the information may comprise at least one of a position andorientation of the treatment device.

In various embodiments, systems and methods are disclosed forcommunicating information from a sensor to a mapping system. For examplethe sensor may communicate information relating to at least one of aposition and orientation of a treatment device.

In various embodiments, systems and methods are disclosed foraggregating information relating to an imaging modality through atracking system. For example the information may comprise at least oneof a position, orientation, and motion of the imaging modality.

Design of computer user interfaces that are useable and easily learnedby humans is a non-trivial problem for software developers. The presentdisclosure describes various embodiments of interactive and dynamic userinterfaces that are the result of significant development. Thisnon-trivial development has resulted in the user interfaces describedherein which may provide significant cognitive and ergonomicefficiencies and advantages over previous methods. The interactive anddynamic user interfaces include improved human-computer interactionsthat may provide reduced mental workloads, improved decision-making,reduced work stress, reduced procedure time, increased procedureaccuracy, increased procedure documentation, and/or the like, for auser. For example, user interaction with the interactive user interfaceincluding interactions with fibroid and/or treatment data, among otherinteractions described herein may provide optimized interactions incomparison to previous methods.

Various embodiments of the present disclosure provide improvements tovarious technologies and technological fields. For example, existingtreatment mapping and planning application technology is limited invarious ways, and various embodiments of the disclosure providesignificant improvements over such technology. For example, existingtreatment mapping and planning application technology is limited sincethe treatment data that is provided may not be presented efficiently orat all and interactions between the treatment devices and the system islimited or not provided at all. Various embodiments of the presentdisclosure are inextricably tied to computer technology. In particular,various embodiments rely on aggregation of fibroid and/or treatmentdata, generating information about a treatment procedure, displayingsuch data in interactive graphical user interfaces displayed onelectronic displays, etc. In some embodiments, treatment data mayinclude information regarding the treatment device(s), the treatmentparameters, the day and/or time of treatment, and other information.Such features are intimately tied to, and enabled by, computertechnology, and would not exist except for computer technology. Forexample, the interactions with displayed data described below inreference to various embodiments cannot reasonably be performed byhumans alone, without the computer technology upon which they areimplemented. Further, the implementation of the various embodiments ofthe present disclosure via computer technology enables many of theadvantages described herein, including more efficient interaction with,and presentation of, various types of electronic data.

Some embodiments of the disclosure are described below in reference tothe appended claims, which may serve as an additional summary of thedisclosure.

In various embodiments, systems and/or computer systems are disclosedthat comprise a computer readable storage medium having programinstructions embodied therewith, and one or more processors configuredto execute the program instructions to cause the one or more processorsto perform operations comprising one or more aspects of the above-and/or below-described embodiments (including one or more aspects of theappended claims).

In various embodiments, computer-implemented methods are disclosed inwhich, by one or more processors executing program instructions, one ormore aspects of the above- and/or below-described embodiments (includingone or more aspects of the appended claims) are implemented and/orperformed.

In various embodiments, computer program products comprising a computerreadable storage medium are disclosed, wherein the computer readablestorage medium has program instructions embodied therewith, the programinstructions executable by one or more processors to cause the one ormore processors to perform operations comprising one or more aspects ofthe above- and/or below-described embodiments (including one or moreaspects of the appended claims).

BRIEF DESCRIPTION OF THE DRAWINGS

The following drawings and the associated descriptions are provided toillustrate embodiments of the present disclosure and do not limit thescope of the claims. Aspects and many of the attendant advantages ofthis disclosure will become more readily appreciated as the same becomebetter understood by reference to the following detailed description,when taken in conjunction with the accompanying drawings, wherein:

FIG. 1 is a flowchart of an illustrative operation of an exampleinteractive treatment mapping and planning system.

FIG. 2 illustrates an example graphical user interface of an interactivetreatment mapping and planning system.

FIG. 3 illustrates an example graphical user interface with aconstructed fibroid map located alongside a user interface of theinteractive treatment mapping and planning system in which various typesof fibroid icons are displayed with a representation of a uterus.

FIG. 4 illustrates an example graphical user interface of theinteractive treatment mapping and planning system in which the fibroidmap indicates that one fibroid has been treated.

FIG. 5 illustrates an example graphical user interface of theinteractive treatment mapping and planning system in which the fibroidmap indicates that all fibroids have been treated.

FIG. 6 illustrates an example of a treatment report that may begenerated by the interactive treatment mapping and planning system inwhich a single fibroid has been treated.

FIG. 7 illustrates another example of a treatment report that may begenerated by the interactive treatment mapping and planning system inwhich several fibroids have been treated.

FIG. 8 is a block diagram that illustrates an example interactivetreatment mapping and planning system.

FIG. 9 is a flowchart of an illustrative operation of an exampleinteractive treatment mapping and planning system.

FIG. 10A is an example diagnostic device of the interactive treatmentmapping and planning system configured to identify fibroids within auterus.

FIG. 10B illustrates an example of a fibroid map interface of theinteractive treatment mapping and planning system in which various typesof fibroid icons can be displayed with a representation of a uterus.

FIG. 10C is an example diagnostic device of the interactive treatmentmapping and planning system configured to identify fibroids within auterus.

FIG. 10D illustrates an example of a fibroid map interface of theinteractive treatment mapping and planning system in which various typesof fibroid icons can be displayed with a representation of a uterus.

DETAILED DESCRIPTION

The present disclosure provides improved systems and methods for thetreatment of tissues such as uterine fibroids. The systems and methodsallow the treating physician to interactively and efficiently accessinformation to assist in the development of a treatment map and plan.Access to such information may facilitate the planning and treatment oftargeted tissues and improve the likelihood that proper treatment of atargeted anatomy occurs. The systems and methods provide a userinterface for real-time dynamic interactions and feedback regardingtreatment data. Such information may allow the physician, if desired, toalter or reassess the treatment plan before and/or during the treatmentprocedure. The systems and methods provide user interfaces that candynamically generate a visual representation of information byaggregating treatment data from one or more of the treatment devices andgenerating useful information.

Feedback or other information is preferably provided visually on atreatment mapping and planning application. The treatment mapping andplanning application may generally have graphical user interfaces thatinclude real-time images overlaid by or alongside various objects andfibroid data. In some embodiments, the images may comprise ultrasonic orother imaging screens. An application may further be able to aggregatereal-time information gathered from one or more treatment devices anddisplay the information in an interactive manner that provides the userwith information. For example, the real-time information may comprisefeedback information in response to manipulating the probe and/oractivating the needles. The system automatically aggregating theinformation reduces the need to enter data or commands onto a systemcontroller or display, and can reduce the risk of data being lostaltogether.

The application may generate a treatment report including informationregarding the fibroid(s), the treatment device, the treatmentparameters, the day and/or time of treatment, and other treatmentinformation.

Although certain preferred embodiments and examples are disclosed below,inventive subject matter extends beyond the specifically disclosedembodiments to other alternative embodiments and/or uses and tomodifications and equivalents thereof. Thus, the scope of the claimsappended hereto is not limited by any of the particular embodimentsdescribed below. The structures, systems, and/or devices describedherein may be embodied as integrated components or as separatecomponents. For purposes of comparing various embodiments, certainaspects and advantages of these embodiments are described. Notnecessarily all such aspects or advantages are achieved by anyparticular embodiment. Thus, for example, various embodiments may becarried out in a manner that achieves or optimizes one advantage orgroup of advantages as taught herein without necessarily achieving otheraspects or advantages as may be taught or suggested herein.

Unless otherwise noted, the systems and methods described herein may beused with any embodiment described and/or contemplated within U.S. Pat.Nos. 8,088,072 and 8,992,427. It will be understood that any of theembodiments described and/or contemplated within U.S. Pat. Nos.8,088,072 and 8,992,427 can be modified to be used with the systems andmethods described herein.

I. Overview

An interactive treatment mapping and planning system enables a user tomore quickly, thoroughly, and efficiently aggregate fibroid and/ortreatment information from a user and/or data source, construct afibroid map providing a visual representation of the aggregated fibroidinformation, generate information from the aggregated information aboutthe fibroid to be treated and/or treatment procedure, develop atreatment plan based on the fibroid and/or treatment procedureinformation, provide real-time information gathered from treatmentdevices during the treatment procedure, and allow the user to interactwith the treatment data. This and other functionality and advantages areprovided via interactive graphical user interfaces, includinginteractive map interfaces, which are inextricably tied to computertechnology.

As mentioned above, the system enables a user to efficiently inputand/or compile fibroid data, construct a fibroid map, develop atreatment plan, gather information regarding the treatment procedure,and generate a treatment report. The interactive treatment mapping andplanning system may include an interactive user interface in whichfibroid and/or treatment data may be displayed on a user interface.

Fibroid data may refer to any type of data and/or information related tothe fibroid(s) to be mapped. Fibroid data may also be referred to hereinas fibroid data items. A fibroid data item generally includes at least alocation associated with a fibroid. The location may be specified by,for example in some embodiments, a designated location selected by theuser on a projected image located on or alongside a user interface. Insome instances, fibroid data may include other information. For example,the fibroid data may comprise a description of the fibroid, fibroidlocation, fibroid type (e.g., intramural, submucosal, subserosal,pedunculated submucosal, pedunculated subserosal), estimated fibroidsize, fibroid prior treatment status, number of fibroids, fibroidtreatment order, and/or other fibroid information. Any combination ofdifferent types of fibroid data items may be used in the systemsimultaneously. Fibroid data items may be from various sources, and maybe associated with various types of fibroids. Fibroid data may beobtained from a user, a single database, and/or multiple databases. Thesingle and/or multiple databases from which fibroid data may be obtainedmay be operated, maintained, and/or owned by various entities. Forexample, the fibroid data may be obtained from a patient database and/ora hospital records management database.

Treatment data may refer to any type of data and/or information relatedto the treatment procedure. Treatment data may also be referred toherein as treatment data items. A treatment data item generally includesat least information regarding the treatment device(s), the treatmentparameters, the day and/or time of treatment, and/or other treatmentinformation. In some instances treatment data may include otherinformation. For example, the treatment data may comprise fibroidtreatment order, treatment time, ultrasound device information (such asultrasound device serial number), ultrasound transducer angle,ultrasound transducer position, ablation device information (such asablation device serial number), needle deployment depth, electrodedeployment length, ablation data, ablation treatment volume, ablationtreatment area, ablation time, ablation temperature, electrode and/ortissue impedance, radiofrequency power, radiofrequency temperature,time-temperature graphs, time-radiofrequency power graphs, and/or othertreatment information. Any combination of different types of treatmentdata items may be used in the system simultaneously. Treatment dataitems may be from various sources. Treatment data may be obtained from auser and/or treatment device(s) throughout a treatment procedure. Forexample, the treatment data may be obtained from various treatmentdevices, such as an ultrasound device and/or an ablation device.

FIG. 1 shows a flowchart depicting an illustrative operation of theinteractive treatment mapping and planning system. In variousembodiments, fewer blocks or additional blocks may be included in theprocesses, or various blocks may be performed in an order different fromthat shown in FIG. 1. In an embodiment, one or more blocks in FIG. 1 maybe performed by, or implemented in, the interactive treatment mappingand planning system 800 shown in FIG. 8.

At block 102, various fibroid data may be optionally received by thesystem from a user input and/or one or more databases and/or datasources (including, for example, from databases maintained by the useror third party entities). As an example of the system receiving variousfibroid data, the system may access fibroid data from one or more datasources. The data may comprise computer-readable output from adiagnostic test such as a transcervical uterine ultrasound, alaparoscopic ultrasound, or intrauterine ultrasound. The diagnostic testmay be performed prior to or contemporaneously with the operationillustrated in FIG. 1.

The data may then optionally be processed by the server at block 104.For example, the fibroid data may be organized by location, type, and/orby any other useful index so as to enable fast searching of the fibroiddata.

At block 106, a user interface (and/or user interface data) is generatedthat displays (and/or is useable to generate and display) a mapinterface, as described in further detail below. For example, a mapinterface detailing a constructed fibroid map, as described in furtherdetail below, may be displayed on the user interface. The map interfacemay be constructed entirely automatically based on the received data,entirely by the user, or a combination thereof. For example, the mapinterface may auto-populate based on the received data and then bemanipulated by the user. In various embodiments, the system creates avisual representation of fibroid data and/or treatment data on thegenerated user interface, including, for example, descriptions of thefibroids, fibroid locations, fibroid type (e.g., intramural, submucosal,subserosal, pedunculated submucosal, pedunculated subserosal), estimatedfibroid sizes, fibroid prior treatment statuses, number of fibroids,fibroid treatment order, and other fibroid information In variousembodiments, the system may create a populated fibroid map following apreliminary exploratory procedure, as described below in reference toFIG. 9.

At block 108, the user may interact with the user interface of thesystem in any of the ways described below. For example, the user mayimport additional data, interact with the map interface, provide varioussearch query criteria, etc. At block 110, the fibroid data may beaccessed by the system based on the provided user actions. In variousembodiments, the treatment system may access one or more internal and/orexternal databases in response to user actions. The one or more accessedinternal and/or external databases may or may not include the fibroiddata described above.

At block 112, the system may develop a treatment plan based on theconstructed fibroid map. The treatment plan may be developed manually bythe user. In some embodiments, the system may develop the treatment planautomatically based on the fibroid data, as described in further detailbelow. The user may modify an automatically created treatment plan(e.g., changing the treatment order of the fibroids, selecting to skiptreatment of some fibroids, etc.). Some changes may be prohibited orgenerate an error or warning message. The system may suggest changes toa manually created treatment plan.

At block 114, the user interface may be updated in response to theuser's actions. The system may update the user interface followinginitiation of the treatment procedure. The updated interface may includedata acquired from a treatment device. For example, the user interfacemay display information regarding the treatment device(s), the treatmentparameters, the day and/or time of treatment, and other treatmentinformation described herein in further detail. Treatment may beprevented by the system unless the treatment can be linked to a specificfibroid. Fibroid information may be displayed in lists and/or in the mapinterface, and/or animations may be provided, among other interfaceupdates described below. As indicated by arrow 116, the operation mayrevert to block 108 such that the user may update and/or input a newaction. After reversion, one or more of blocks 106, 108, 110, and/or 112may be skipped.

At block 118, the system determines whether the treatment procedure hasbeen terminated. The system may determine whether sufficient treatmenthas been performed prior to terminating the treatment procedure. In someembodiments, the system may not terminate the treatment procedure if thesystem determines that additional treatment is required. As indicated byarrow 120, if the treatment procedure has not terminated, the operationmay continue to update the user interface as the user interacts with thesystem in any of the various ways described here. If the treatmentprocedure has terminated, the process proceeds to block 122.

In various embodiments, fibroid and/or treatment data may be receivedand processed by the system at any time and/or continuously. In anembodiment, treatment data may be updated even as the user is viewingthe data on the user interface. For example, the user may use the systemto analyze substantially real-time treatment data.

At block 122, the system may generate a report following the terminationof the treatment procedure. The report may detail treatment informationacquired during the treatment procedure. For example, the report mayinclude information regarding the fibroid(s), the treatment device, thetreatment parameters, the day and/or time of treatment, etc. The reportis described in further detail below.

The system may generate alerts to the user. Alerts may compriseelectronic notifications of changes and/or updates, for example, relatedto a user's actions. For example, as treatment data is updated in thesystem, the system may determine new or different fibroidclassification, or may determine that user interfaces are or would beupdated as a result of the updates. Accordingly, in order that the usermay be made aware of these changes in a timely manner, an alert and/ornotification may be automatically transmitted, for example, to a deviceoperated by the user. The alert and/or notification can be transmittedat the time that the alert and/or notification is generated or at somedetermined time after generation of the alert and/or notification. Whenreceived by the device, the alert and/or notification can cause thedevice to display the alert and/or notification via the activation of anapplication on the device. In some embodiments, the device may comprisea browser, a mobile application, etc. For example, receipt of the alertand/or notification may automatically activate an application on thedevice, such as a messaging application, a standalone application, or abrowser, for example, and display information included in the alertand/or notification. In some embodiments, the standalone application maycomprise an interactive treatment mapping and planning systemapplication. An alert may include notification that one or more fibroidswas not treated, a treatment parameter may be inconsistent with theestimated fibroid size, there was a problem with the treatment device ora portion thereof (e.g., one or more thermocouples providinginconsistent data), etc.

Embodiments of the disclosure will now be described with reference tothe accompanying figures, wherein like numerals refer to like elementsthroughout. The terminology used in the description presented herein isnot intended to be interpreted in any limited or restrictive manner,simply because it is being utilized in conjunction with a detaileddescription of certain specific embodiments of the disclosure.Embodiments of the disclosure may include several novel features, nosingle one of which is solely responsible for its desirable attributesor which is essential to practicing the embodiments of the disclosureherein described.

II. Example User Interface and Constructing a Fibroid Map

FIGS. 2-5 illustrate an example of a graphical user interface 200 of theinteractive treatment mapping and planning system. The user interface200 may include an imaging field 202 displaying real-time imagesobtained from an ultrasound device or another imaging modality. The userinterface 200 may further comprise a fibroid map interface 204 to assista user before and/or during a treatment procedure. The fibroid mapinterface 204 may allow a user to obtain a comprehensive view of themapped fibroids and develop a treatment plan prior to initiating atreatment procedure. The fibroid map interface 204 may be created usingdiagnostic images from an ultrasound device. The fibroid map interface204 may be based on diagnostic data derived from other systems. Thefibroid map interface 204 may display one or more images orillustrations of a uterus. For example, in some embodiments the fibroidmap interface 204 may display several views of the uterus. As shown inFIGS. 2-5, the several views may include a uterus front view 206 and/ora uterus side view 208. The one or more uterus views 206, 208 may beannotated with directional indicators (e.g., left, right, lateral,medial, anterior, posterior, dorsal, ventral, inferior, superior) toorient a user interacting with the one or more uterus views 206, 208.For example, a uterus front view 206 may indicate a right side and/orleft side. For another example, a uterus side view 208 may indicate ananterior side and/or a posterior side.

The fibroid map interface 204 may be located at various portions of theuser interface 200. In some embodiments, the fibroid map interface 204may overlay a portion of the user interface 200 (e.g., as shown in FIGS.2-5). The user may interact with the fibroid map interface 204 to resizethe fibroid map interface 204 and/or move the fibroid map interface 204throughout any portion of the user interface 200, for example to changeobstruction of the view of the imaging field 202. In some embodiments,the user interface 200 may comprise a separate viewing window or asplit-screen window providing the fibroid map interface. In this case,the fibroid map interface 204 will not be displayed obstructing theimaging field 202.

The user interface 200 and/or fibroid map interface 204 may furthercomprise several additional icons or buttons to increase the system'sfunctionalities. In some embodiments, the user interface 200 maycomprise a fibroid map interface view button 210. When a user engagesthe view button 210, the system may display the fibroid map interface204. The system may subsequently remove the fibroid map interface 204from view when the user again engages the view button 210. In someembodiments, the fibroid map interface 204 may be removed from view whena user engages a fibroid map interface close button 212. In someembodiments, the fibroid map interface may be removed from view orreduced in size upon user actions such as operation of a treatmentdevice.

The user interface 200 and or fibroid map interface 204 may furthercomprise a treatment report button 214 that, when engaged by the user,causes the system to generate a treatment report 600, 700, discussed infurther detail below.

In various embodiments, functionality of the interactive treatmentmapping and planning system (as described in reference to the variousfigures below) may be implemented in one or more software computermodules stored in a memory and executed by one or more hardwareprocessors, as is described below with reference to the exampleinteractive treatment mapping and planning system 800 in FIG. 8. Thesystem 800 can be designed to operate with the treatment device, displaythe user interface 200, and/or generate the treatment report 600, 700.

In various embodiments, the user interface 200 of FIGS. 2-5 may bedisplayed on an electronic display viewable by a user of the interactivetreatment mapping and planning system. The user of the interactivetreatment mapping and planning system may interact with the userinterface 200 of FIGS. 2-5 by, for example, touching the display whenthe display is touch-enabled, using a mouse pointer to click on thevarious elements of the user interface 200, and/or using a keyboard toinput data.

The user of the system may interact with the user interface 200 byscrolling or panning up, down, and/or side to side; zooming in or out;selecting data items; drawing shapes; performing a search queries;and/or the like. Various user actions may reveal more or less userinterface 200 and/or fibroid map interface 204 detail, and/or more orfewer data items.

FIG. 3 illustrates an example user interface 200 of the interactivetreatment mapping and planning system in which various types of fibroiddata items are displayed, according to block 106 of FIG. 1. In someembodiments, the system utilizes the graphical fibroid map interface 204to display visual representations that provide the user with insightfulinformation about a mapped fibroid. In some embodiments, the systemdisplays a visual representation that provides the user with informationrelating to fibroid data, among other information, without the userhaving to go back to the one or more fibroid data source(s).

Prior to initiation of a treatment procedure, the system receivesfibroid data. In some embodiments, a user may interact with the userinterface 200 and/or fibroid map interface 204 to manually populate thefibroid map interface 204 with fibroid information. The user may reviewfibroid information based on previously gathered diagnostic results.After locating one or more fibroids through a preliminary ultrasound orother imaging modality exploratory procedure, the user may input thefibroid information into the user interface 200 and/or fibroid mapinterface 204. The system may automatically populate the fibroid mapinterface 200 with fibroid information. During the preliminaryexploratory procedure, the system may generate fibroid information byaggregating information from a user and/or one or more separate datasources, discussed in further detail below with reference to FIG. 9. Insome embodiments, as described above, the system may automaticallyobtain fibroid data from single and/or multiple databases from whichfibroid data may be obtained may be operated, maintained, and/or ownedby various entities. The one or more databases may include a patientdatabase and/or a hospital records management database. Following inputof the fibroid information, either manually by the user or automaticallyby the system, the system may track and record the fibroid information.

Various data items, including fibroid data items, may be represented onthe fibroid map interface 204 with icons and/or symbols. FIGS. 2-5illustrate several examples of fibroid icons 216 that may representfibroid data on the uterus views 206, 208. The user may select and/orotherwise interact with fibroid data for each fibroid icon 216 displayedon the fibroid map interface 204. In various embodiments, the system maydisplay a fibroid icon 216 as a representation of fibroid data,including for example, a description of the fibroid, fibroid location,estimated fibroid size, fibroid prior treatment status, number offibroids, fibroid treatment order, and other fibroid information.

A user may manually populate the fibroid map interface 204 byinteracting with a fibroid icon 216 within a fibroid icon selection tray218. As discussed above, a user may interact with the system throughvarious means. For example, the user may click and drag a fibroid icon216 to a desired location. For another example, the user may click afibroid icon 216 and subsequently click a desired location to place thefibroid icon 216 at the location. The user may click a desired locationto place the fibroid icon 216 and subsequently click a fibroid icon 216to place the fibroid icon 216 at the location. When a user places afibroid icon 216 in one uterus view 206, 208, the system mayautomatically populate the other uterus view 206, 208 with a fibroidicon 216 at the same location on the uterus. The user may alter thelocation of the fibroid icon 216 by interacting with the fibroid icon216. In some embodiments, when a user moves a fibroid icon 216 up ordown in a single uterus view 206, 208, the system may automatically movea corresponding fibroid icon 216 in another uterus view 206, 208. As auser moves a fibroid icon 216 left or right in a single uterus view 206,208, the system may not alter the location of a corresponding fibroidicon 216 in another uterus view 206, 208. This allows the fibroid icon216 to maintain the representative horizontal location of the fibroidicon 216 on the fibroid map interface 204.

In various embodiments, the system displays each fibroid icon 216 on thefibroid map interface 204 through a particular visual representation.Each fibroid icon 216 may represent a fibroid type associated with afibroid data item. The fibroid icon 216 may be chosen from a fibroidicon selection tray 218 based on the properties of the fibroid, asdiscussed in further detail below. The visual representation may becapable of quickly and efficiently providing the user with valuablefibroid information. The system may assign the particular representationto the fibroid data item based on fibroid information generated from theaggregated information. The visual representations of the fibroid icons216 may be animated to show, among other things, recent activity, suchas a change in fibroid treatment status, fibroid treatment order, orother fibroid information.

The fibroid icon 216 may comprise different sizes to representvariations in the estimated fibroid size. For example, as shown in FIG.3, the fibroid icon 216 may be selected from a large fibroid icon 216A,medium fibroid icon 2168, and small fibroid icon 216C displayed withinthe fibroid icon selection tray 218. The fibroid selection tray 218 maycomprise a conical or frustoconical scale where a user can click alongthe longitudinal axis to select from an analog assortment of sizes. Thefibroid selection tray 218 may prompt user input of a numerical fibroidestimated size and then base the fibroid icon 216 thereon. A fibroidicon 216 may provide a user with the ability to interact with thefibroid icon 216 to alter the properties of the fibroid icon 216. Forexample, a user may click and drag on a portion of the fibroid icon 216to increase or decrease the size of the fibroid icon 216. This providesthe user with the option to vary the fibroid icon 216 size to anyrepresentative fibroid size desired. Fibroid icons 216 may becircular/spherical (e.g., as shown in FIGS. 2-5) or oblong, elliptical,egg-shaped, or other shapes. In such embodiments, the fibroid icons 216may be stretched, narrowed, rotated, etc. The user may alter theproperties of the fibroid icon 216 prior to and/or after the fibroidicon 216 is placed on the fibroid map interface 204. Fibroid icons 216may be a graphical representation illustrating the relative fibroid sizeand fibroid location in a uterus.

As shown in FIG. 3, a fibroid map interface 204 may display variousvisual representations that provide the user with insightful informationabout the mapped fibroid(s). For example, fibroid icon 217 indicates thepresence of a large (216A-sized) fibroid located on the posterior sideof the right wall of the uterine cavity. The fibroid icon 217 is yellow,which indicates that the fibroid is untreated. As shown in FIGS. 4 and5, a white fibroid icon indicates that the fibroid has been treated.Other colors and schemes for indication of treatment are also possible.For example, a grey-scale color scheme may be used to differentiatefibroid icons 216 indicating untreated and treated fibroids. The fibroidtreatment status may be altered during and/or after a treatmentprocedure, as described below. FIG. 3 also shows three other fibroidshaving various estimated sizes and locations.

In some embodiments, the user may select (e.g., by clicking on, hoveringover, etc.), via the fibroid map interface 204, one or more of thefibroid icons 216 displayed to cause the system to display additionalfibroid details. The additional information may be displayed in thefibroid map interface 204 or in a separate portion of the user interface200. These capabilities can increase user efficiency by granting theuser access to fibroid data through the user interface 200.

In some embodiments, the user may further interact with a fibroid icon216 to alter various other fibroid properties, such as fibroid treatmentorder (e.g., if the number indicates order of treatment, changing thenumber), fibroid treatment status (e.g., marking as treated), fibroidlocation (e.g., as described above), and/or other fibroid information.

In some embodiments, the user interface 200 and/or fibroid map interface204 may comprise a legend.

Embodiments of the interactive treatment mapping and planning systemrelate to systems that facilitate the treatment of a fibroid. It will beunderstood by one of skill in the art that the fibroids described hereinthis specification may encompass any fibroid, and are not limited to aparticular location or type of fibroid. It is to be understood that theterm fibroid is to be broadly construed and encompasses any abnormaltissue growth or any other superficial or other conditions orimperfections within the uterus of the patient or otherwise that benefitfrom ablation treatment. For example, the term fibroid may be usedherein to describe ectopic glandular tissue or myometrial found in themuscular wall of the uterus (adenomyosis or uterine endometriosis).

III. Developing a Treatment Plan

At block 112 of FIG. 1, the user may develop a treatment plan based onthe fibroid map interface 204 following the construction of the fibroidmap interface 204. In alternative embodiments, the system mayautomatically develop a treatment plan based on the constructed fibroidmap interface 204 and aggregated fibroid information. The treatment planmay comprise illustrating fibroid icons 216 on the fibroid map interface204 to include numbering indicating a fibroid treatment order, as shownin FIGS. 3-5. The user and/or system may alter the fibroid treatmentorder for a fibroid icon 216. An automated fibroid treatment order maybe based on one or more parameters including, for example, fibroid size(e.g., largest to smallest, smallest to largest), fibroid location(e.g., most superior to most inferior, most inferior to most superior,most submucosal to most subserosal), likelihood of outgassing, ease ofaccess, combinations thereof, and the like. Parameters may be providedwith weighted scores to recommend, as a non-limiting example, treatmentof a superior small submucosal fibroid before treatment of an inferiormedium intramural fibroid.

The treatment plan may target a fibroid(s) farthest from serosa prior toa fibroid(s) closest to serosa. The treatment plan may targetpedunculated submucosal fibroid(s), submucosal fibroid(s), intramuralfibroid(s), subserosal fibroid(s), and lastly pedunculated subserosalfibroid(s), in the order recited.

In some embodiments, the fibroid treatment order may be designed toavoid obscuring of the imaging field 202. Obscuring may arise through aprocess referred to as outgassing that occurs when steam created duringablation of a fibroid alters the quality of images produced byultrasound or other imaging modalities. As such, a treatment plan may bedeveloped to avoid outgassing. Several factors may affect the extent towhich outgassing occurs during the treatment procedure, such as themapped fibroid location, the fibroid size, other fibroid information,treatment parameters (e.g., temperature, time, temperature ramping,etc.), etc. In some embodiments, a treatment plan may be developed thattreats fibroids located farther within a uterine cavity prior totreating fibroids located closer to the cervix. Alternatively, fibroidslocated closer to the cervix may be treated before fibroids locatedfarther within the uterine cavity. A treatment plan may be developed totreat fibroids located closer to the surface of the uterine lining asopposed to fibroids located deeper within the uterine walls. Fibroidsize may be a factor in determining fibroid treatment order. Embodimentsof the interactive treatment planning and mapping system may utilize acombinatorial optimization algorithm to determine an improved or optimalfibroid treatment order subject to treatment constraints and/ortreatment parameters (e.g., temperature, time, temperature ramping,reducing or avoiding outgassing, fibroid size, fibroid location, numberof fibroids, etc.).

In some embodiments, the imaging field 202, the fibroid map interface204, or a combination of both may be utilized to determine placementand/or location of the treatment device during the treatment procedure.The interactive treatment planning and mapping system may determineplacement and/or location of the treatment device based on fibroid dataand treatment data. Several factors may affect the placement of thetreatment device, such as the mapped fibroid location, the fibroid size,other fibroid information, treatment parameters (e.g., temperature,time, temperature ramping, etc.), and other information. The userinterface may further comprise treatment device placement and/orlocation indications on the imaging field 202, the fibroid map interface204, or a combination of both. The indications may instruct the user toplace the treatment device in a particular position and/or locationduring the treatment procedure. Embodiments of the interactive treatmentplanning and mapping system may utilize a combinatorial optimizationalgorithm to determine an improved or optimal treatment device locationand/or placement subject to treatment constraints and/or treatmentparameters (e.g., temperature, time, temperature ramping, reducing oravoiding outgassing, fibroid size, fibroid location, number of fibroids,etc.).

The treatment device, in some instances, may be configured to sense itsposition and/or orientation in space. The treatment device can transmitits position and/or orientation information to the interactive treatmentplanning and mapping system. The system may incorporate the positionand/or orientation information into the imaging field 202, the fibroidmap interface 204, or a combination of both to be displayed to a user.The treatment device may include one or more sensors to measure theposition and/or orientation in three-dimensional space of the treatmentdevice. The sensors may communicate the position and/or orientationinformation to the interactive treatment planning and mapping system,such that a position and/or orientation information of the treatmentdevice can be displayed in the imaging field 202 and/or fibroid mapinterface 204. In some instances, the treatment device is in the form ofan ablation tool comprising a needle, but the treatment device caninclude other ablation and/or imaging devices, or may only include animaging device (e.g., for diagnostic uses).

In some embodiments, the treatment device comprises one or more sensorsconfigured to measure an insertion depth of the treatment device duringa treatment procedure. The insertion depth can be communicated to theinteractive treatment planning and mapping system such that depth of thetreatment device can be displayed in the imaging field 202, the fibroidmap interface 204, or a combination of both. In some instances, thetreatment device is configured to measure an insertion angle of thetreatment device during a treatment procedure. The insertion angleinformation may be transmitted to the interactive treatment planning andmapping system to be displayed in the imaging field 202, the fibroid mapinterface 204, or a combination of both.

In some embodiments, the treatment device may include one or moresensors configured to determine a device position and/or orientationrelative to other objects, such as, for example, a fibroid location, auser, one or more locations on a patient, combinations thereof, and thelike. Information corresponding to the sensed position and/ororientation is transmitted to the interactive treatment planning andmapping system. Position and/or orientation information between thetreatment device and a fibroid to be ablated may be captured by anexternal tracking system, such as, by way of non-limiting example, anoptical tracking system. The tracking system can be configured to obtainat least one of position, orientation, and motion information of thetreatment device used. The information sensed by the tracking system canbe transmitted to the interactive treatment planning and mapping system.The system may be configured to receive the information and to displayit in the imaging field 202, the fibroid map interface 204, or acombination of both. The position and/or orientation information may bedetermined by any suitable approaches to measure and determine theposition and orientation of an object in three-dimensional space. Forexample, an optical tracking system and/or inertial sensors (forexample, gyroscope sensors and/or accelerometers) can be configured toobtain one or more of position, orientation, and motion information ofthe treatment device. In some instances, the treatment device mayinclude visual markers that provide placement and/or locationindications to a user. For example, the treatment device may beannotated with positional indicators (e.g., depth indications) along atleast a portion of the treatment device to orient a user interactingwith the treatment device. Indicators may be active (e.g.,light-emitting diodes) and/or passive (e.g., optically recognizablepatterns).

In some implementations, the treatment device may comprise an alignmentsystem that periodically emits a signal which is may be captured by oneor more corresponding receivers. In some embodiments, the one or morereceivers may sense the signal from the treatment device directly. Thealignment system may comprise a source of electromagnetic radiation andemit a signal comprising electromagnetic radiation. For example, thesource may be configured to transmit a signal that is capable oftraveling through one or more portions of a patient anatomy to bereceived by a corresponding receiver located outside of a patientcavity.

The position and/or orientation information transmitted to theinteractive treatment planning and mapping system may be used inconjunction with fibroid data so that the locations of the treatmentdevice in the imaging field 202 and/or the fibroid map interface 204correspond to an actual location of the treatment device relative to oneor more fibroids. The ability to obtain position and/or orientation dataof the treatment device as the user is performing a treatment ordiagnostic procedure can help the user perform a fibroid treatment at anoptimal location. For example, during a treatment procedure, theinteractive treatment planning and mapping system may instruct a uservia the imaging field 202 and/or fibroid map interface 204 to guide thetreatment device to an appropriate depth, position, and/or orientationfor a therapeutic procedure. In some instances, the movement of thetreatment device can be projected on the imaging field 202 and/orfibroid map interface 204 in real-time during the treatment procedure.For example, as the treatment device is moved through a patient cavity,the location of a distal tip of the treatment device can be identifiedon the imaging field 202 and/or fibroid map interface 204. When thetreatment device is positioned in a target location within the patientcavity, the treatment device may be positioned in the target location inthe imaging field 202 and/or fibroid map interface 204. Updating A UserInterface with Treatment Data

At block 114 shown in FIG. 1, the user interface 200 may be updatedbefore and/or during a treatment procedure in response to the user'sactions. In some embodiments, the system may update the user interface200 following initiation of the treatment procedure. The updated userinterface 200 may include data acquired from the treatment devices, suchas an ultrasound device and an ablation device. For example, asdiscussed above, the user interface 200 may display informationregarding the treatment device(s), the treatment parameters, the dayand/or time of treatment, and other treatment information describedherein in further detail. In some embodiments, as shown in FIGS. 4-5,the fibroid map interface 204 may be updated to include treatmentparameters 220. The displayed treatment parameters may comprise anultrasound transducer angle relative to needle longitudinal axis(“Angle”), an ablation diameter along the minor axis (“Size”), needledeployment depth (“Intro”), electrode deployment length, and/or othertreatment data.

The user interface 200 may further comprise a treatment data interface222 detailing the elapsed treatment time, treatment time remaining,ablation treatment volume, ablation treatment area, ablation time,ablation temperature, electrode and/or tissue impedance, radiofrequencypower, radiofrequency temperature, and/or any other desired treatmentdata. In some embodiments, the treatment data interface 222 may comprisea power graph 224 illustrating the relationship between time andradiofrequency power. The treatment data interface 222 may comprises atemperature graph 226 illustrating the relationship between time andmapped fibroid temperature.

In various embodiments, fibroid and/or treatment data may be receivedand processed by the system at any time and/or continuously. Asindicated by block 118 in FIG. 1, the system may determine whether thetreatment procedure has been terminated. In some embodiments,termination can be determined by the user clicking the treatment reportbutton 214 or the completed treatment of all mapped fibroids. If thetreatment procedure has not been terminated, the system may continuouslyupdate the user interface 200 as the treatment procedure continues, asshown by arrow 120. In an embodiment, treatment data may be updated evenas the user is viewing the data on the user interface 200. For example,the user may use the system to analyze substantially real-time treatmentdata through the treatment interface 222 and/or fibroid map interface204.

In various embodiments, the system may provide color codedrepresentations. For example, the system may characterize a fibroid icon216 into various classifications such as treatment statusclassifications: untreated, treated, previously treated but recurringfibroid, or untreated with a previous failed treatment attempt. Theindividual classifications may result in variations in the visualrepresentation of the fibroid icon 216. For example, as shown in FIG. 4,color coded representation of fibroid icon 217T may indicate a treatedfibroid, while fibroid icon 219U may represent an untreated fibroid. Theuser may interact with a fibroid classification before, during, and/orafter a treatment procedure. In some embodiments, a user may manuallychange a fibroid icon 216 to modify the treatment status of a fibroidicon 216 from “untreated” to “treated” after treating the fibroid.Alternatively, the system may automatically modify the fibroid icon's216 treatment status based on treatment data received from the treatmentdevice(s). The change in treatment status may automatically alter thevisual representation of the fibroid icon 216 to properly indicate theupdated fibroid treatment status. In some embodiments, theclassification of an untreated fibroid may initiate a warning or alertto the user relating to the fibroid. If a fibroid is treated for asecond time, for example because a first treatment was not able tocapture the entire fibroid or the portion of the fibroid to be treated,the fibroid icon 216 may change to a third color, have a treatmentquantity indicator (e.g., “2”), combinations thereof, and the like.

IV. Example Treatment Report

As discussed previously, at block 122 in FIG. 1, the system mayautomatically generate a treatment report 600, 700 following thetermination of the treatment procedure, as shown in FIGS. 6-7. A usermay interact with the treatment report button 214 to instruct the systemto generate a treatment report 600. For example, the report 600 of FIG.6 may be generated by a user clicking the treatment report button 214after treating the fibroid 217T at the time of FIG. 4, and the report700 of FIG. 7 may be generated by a user clicking the treatment reportbutton 214 after treating all of the fibroids at the time of FIG. 5.

The treatment report 600, 700 may detail treatment information acquiredduring the treatment procedure. For example, the treatment report 600,700 may include information relating to fibroid location, estimatedfibroid size, fibroid treated status, number of fibroids, fibroidtreatment order, ultrasound device information (such as ultrasounddevice serial number), ultrasound transducer angle, ablation deviceinformation (such as ablation device serial number), needle deploymentdepth, electrode deployment length, planned fibroid size, ablation data,ablation data, ablation treatment volume, ablation treatment area,ablation time, ablation temperature, electrode and/or tissue impedance,radiofrequency power, radiofrequency temperature, time-temperaturegraphs, time-radiofrequency power graphs, ablation safety zone distance,photographs and/or screen shoots of the imaging field, treatmentprocedure information, time of treatment, treatment length, treatmentdate, patient data, attending physician and/or nurse, user and/orphysician notes, and other fibroid and/or treatment information.

FIG. 6 illustrates an example treatment report 600. In some embodiments,the treatment report 600 may include the fibroid map interface 204 alongwith an individual fibroid report 602. For example, as shown in FIG. 6,the treatment procedure may have been limited to a single fibroid. Inthis instance, the treatment report 600 may include only one fibroidreport 602. The report may include information about all mappedfibroids, only treated fibroids (e.g., as shown in FIG. 6), or a subsetof selected fibroids. The report may include a warning flag related to afibroid (e.g., red text indicating a treatment time not commensuratewith an estimated size). The treatment report 700 may include multiplefibroid reports 702, as shown in FIG. 7.

In some embodiments, the treatment report 600, 700 and/or fibroidreport(s) 602, 702 may be exported to one or more databases. The systemmay export the report 600, 700 through wired and/or wirelessconnections.

V. Exploratory Procedure

The interactive treatment mapping and planning system may incorporate apreliminary exploratory procedure. The system may enable a user to moreefficiently aggregate fibroid information during an exploratoryprocedure, construct a fibroid map providing a visual representation ofthe aggregated fibroid information, and generate an exploratory report.

FIG. 9 shows a flowchart depicting an illustrative operation of thepreliminary exploratory procedure. In various embodiments, fewer blocksor additional blocks may be included in the processes, or various blocksmay be performed in an order different from that shown in FIG. 9. In anembodiment, one or more blocks in FIG. 9 may be performed by, orimplemented in, the interactive treatment mapping and planning system800 shown in FIG. 8.

At block 902, various fibroid data may be identified during apreliminary exploratory procedure performed via a diagnostic test suchas a transcervical uterine ultrasound, laparoscopic ultrasound, orintrauterine ultrasound. The system may receive the fibroid data fromthe imaging device(s) at block 904.

In some instances, at block 902, diagnostic device placement and/orlocation data may be identified during a preliminary exploratoryprocedure. The interactive treatment mapping and planning system mayutilize any structure, device, method, or features described herein inrelation to the treatment device. For example, the diagnostic device mayinclude one or more sensors to measure the position and orientation inthree-dimensional space of the diagnostic device. The diagnostic devicecan transmit its position and/or orientation information to theinteractive treatment planning and mapping system. The system mayincorporate the position and orientation information into a userinterface to be displayed to a user. The method may end after suchautomated mapping.

At block 906, a user interface is generated that displays (and/or isuseable to generate and display) a fibroid map interface similar to theuser interface and fibroid map interface previously described above withreference to FIGS. 2-5. The fibroid map interface may be constructedentirely automatically based on the received data, entirely by the user,or a combination thereof. For example, the map interface mayauto-populate based on the received data and then be manipulated by theuser. In various embodiments, the system creates a visual representationof fibroid data on the generated user interface, including, for example,descriptions of the fibroids, fibroid locations, fibroid type (e.g.,intramural, submucosal, subserosal, pedunculated submucosal,pedunculated subserosal), estimated fibroid sizes, fibroid priortreatment statuses, number of fibroids, fibroid treatment order, andother fibroid information. In some embodiments, the system creates avisual representation of diagnostic device data on the generated userinterface, including, for example, a position, orientation, motion,and/or other device information.

FIGS. 10A-10D illustrate an example of a diagnostic device 1002 and afibroid map interface 1004. The fibroid map interface 1004 may utilizeany structure, device, method, or features described herein in relationto the interactive treatment mapping and planning system. In someinstances, the system may receive fibroid data from the diagnosticdevice 1002 to auto-populate the fibroid map interface 1004 with fibroidinformation. Through an exploratory procedure, the diagnostic device1002 may transmit fibroid information (e.g., fibroid location) to thesystem to input into the fibroid map interface 1004. Transmission offibroid information may be based at least partially on sensor data(e.g., providing position and/or orientation information), for examplein accordance with certain devices described herein. After locating afirst fibroid, the system may automatically populate the fibroid mapinterface 1004 with the fibroid information. For example, as illustratedin FIGS. 10A and 10B, the diagnostic device 1002 may identify fibroid 1and transmit fibroid information to allow the system to display afibroid icon 1 on the fibroid map interface 1004. In some embodiments,the diagnostic device 1002 may identify a plurality of fibroids andtransmit a plurality of fibroid information to be displayed on thefibroid map interface 1004. FIGS. 10C and 10D illustrate that, in someinstances, the diagnostic device 1002 may identify fibroid 2 andtransmit fibroid information to allow the system to display a fibroidicon 2 on the fibroid map interface 1004. As described herein, thesystem may generate fibroid information by aggregating information fromthe diagnostic device.

At block 908, the system determines whether the exploratory procedurehas terminated. As indicated by arrow 910, if the exploratory procedurehas not terminated, the operation may continue to identify additionalfibroid(s). For example, with reference to FIG. 3, the fibroid icon 217may be generated on a first pass of blocks 902, 904, 906, 908, and thena second icon may be generated on a second pass blocks 902, 904, 906,908, etc. At each block 906, fibroid icons from that pass and previouspasses may be updated. If the exploratory procedure has terminated, theprocess proceeds to block 912.

At block 912, the system may automatically generate an exploratoryreport following the termination of the exploratory procedure. Thereport may detail exploratory information acquired during theexploratory procedure. For example, the report may include informationregarding the fibroid(s), the imaging device (e.g. an ultrasoundtransducer), the imaging parameters, the day and/or time of exploratoryprocedure, and other information. The exploratory report may include anautomated and/or manual treatment protocol recommendation (e.g.,labeling fibroid icons based on a recommended treatment order ratherthan the order in which the fibroids were diagnosed).

In various embodiments, the system may export a fibroid data filecomprising the constructed fibroid map interface and/or exploratoryreport. The exploratory report may be readable to automatically populatea fibroid interface map 204.

VI. Implementation Mechanisms

FIG. 8 is a block diagram that illustrates an example of an interactivetreatment mapping and planning system 800 that can implement the variousmethods and functionality described herein (e.g., the operation methodsdescribed with reference to FIGS. 1 and 9 and the user interfaces 200described with reference to FIGS. 2-5, and the reports 600, 700described with reference to FIGS. 6 and 7).

As previously discussed, the interactive treatment mapping and planningsystem 800 may comprise an imaging device 814 (e.g. an ultrasoundtransducer or other imaging modality), a display device 816, and anablation device 818 configured to generate radiofrequency energy for thetreatment of an abnormal tissue growth. The treatment system 800 maycomprise any embodiment described and/or contemplated within U.S. Pat.No. 8,088,072 (herein referred to as the '072 Patent) and U.S. Pat. No.8,992,427 (herein referred to as the '427 Patent), incorporated hereinby reference in their entireties. It will be understood that any of theembodiments described and/or contemplated within the '072 Patent and the'427 Patent can be modified to be used with the various interactivetreatment mapping and planning systems described herein. For example, insome embodiments, FIGS. 1 and 2 of the '427 Patent depict the treatmentsystem 800 illustrated in FIG. 8 of the present application. In someembodiments, the treatment system 800 may comprise treatment probe 16,the imaging device 814 may comprise imaging component 28, and theablation device 818 may comprise needle component 26, as shown in FIG. 2of the '427 Patent.

The interactive treatment mapping and planning system 800 can include acomputing engine 806, a data source 804, an imaging device 814, adisplay device 816, and an ablation device 818. The system 800 canreceive user (e.g., physician) input from one or more user computingdevices 802. In an embodiment, the computing device(s) 802 may be anycomputing devices capable of displaying software applications to a userand receiving input from the user. For example, the computing device(s)802 may include smartphones, tablets, laptops, and/or other types ofcomputing devices. The computing device(s) 852 may be capable ofcommunicating over a network, for example, to request data from, and/orto provide data to, the components of the system 800. In someembodiments, the data source 804 may include non-transitorycomputer-readable medium storage for storing fibroid data 811 a and/ortreatment data 811 b.

The computing engine 806 may perform a variety of tasks to implement theoperations of the interactive treatment mapping and planning system. Thecomputing engine 806 can include a hardware processor 808, a memory 810(which can store code modules executed by the processor 808), and acommunication interface 812 that communicates information to and/or fromother components of the system 800.

The computing engine 806 may include one or more software modules storedin the memory 810 and that, when executed by the processor 808, may, forexample, receive fibroid data 811 a and/or treatment data 811 b from thedata source 804, process the received data, generate user interfaces 200and/or user interface data for display by the display device 816,process inputs from the user received from the computing device 802 orvia the user interface (UI) 200 of the display device 816, and/or updatethe user interface 200. The processor 808 may be programmed to performembodiments of the methods described with reference to FIGS. 1 and 9.

The computing engine 806 may be in communication with the data source804. The database 804 may include electronic storage local to thecomputing engine 806. The data source 804 may be embodied in hard diskdrives, solid state memories, and/or any other type of non-transitory,computer-readable storage medium remotely or locally accessible to thecomputing engine 806. The fibroid data 811 a and/or the treatment data811 b may be distributed or partitioned across multiple storage devices,and/or may be combined into a single database.

In various embodiments, the computing engine 806 or data source 804 maybe accessible by the user through a web-based viewer, such as a webbrowser, executed by the user computing device 802 or displayed as thedisplay device 816. The display device 816 may be a computer monitor, atouchscreen, an electronic (e.g., LCD or LED) display, etc. The userinterface may be generated by the computing engine 806 and transmittedto the web browser of the user computing device 802 or the displaydevice 816. Alternatively, data necessary for generating the userinterface 200 may be provided by the computing engine 806 to the displaydevice 816, where the user interface may be generated for display. Theuser may interact with the user interface 200 through the web-browser orthe display device 816. In an embodiment, the user interface 200 of theinteractive treatment mapping and planning system 800 may be accessiblethrough a dedicated software application (rather than a web browser).

The interactive treatment mapping and planning system 800 and othermethods and techniques described herein can be implemented by one ormore special-purpose computing devices such as the processor 808 and thememory 810. The special-purpose computing devices may be hard-wired toperform the techniques, or may include digital electronic devices suchas one or more application-specific integrated circuits (ASICs) or fieldprogrammable gate arrays (FPGAs) that are persistently programmed toperform the techniques, or may include one or more general purposehardware processors specially programmed to perform the techniquespursuant to program instructions in firmware, in executable code modulesstored in the memory 810, other storage, or a combination. Suchspecial-purpose computing devices may combine custom hard-wired logic,ASICs, or FPGAs with custom programming to accomplish the techniques.The special-purpose computing devices may be desktop computer systems,server computer systems, portable computer systems, handheld devices,networking devices or any other device or combination of devices thatincorporate hard-wired and/or specialized program logic to implement thetechniques described herein. Execution of the sequences of instructionscontained in the memory 806 causes the processor(s) 804 to perform theprocess steps described herein.

VII. Examples

1. A system comprising:

-   -   a non-transitory computer readable storage medium configured to        store program instructions; and    -   a processor programmed to execute the program instructions to        cause the processor to:    -   aggregate, from one or more data sources, a plurality of fibroid        data records;    -   extract, from the plurality of fibroid data records, fibroid        data record items; and    -   generate user interface data for rendering an interactive user        interface on an electronic display, the interactive user        interface including:    -   an interactive fibroid map, and    -   a visual representation of a fibroid data record item, the        visual representation comprising a marker on the interactive        fibroid map at a respective fibroid location associated with the        fibroid data item, the visual representation configured to        provide information relating to the fibroid data record item.

2. The system of Example 1, wherein the processor is programmed toaggregate a plurality of fibroid data records from at least one of:

-   -   an input from a user;    -   a user data source; or    -   a third party data source.

3. The system of any one of Examples 1-2, wherein the fibroid datarecord item comprises a fibroid location.

4. The system of any one of Examples 1-3, wherein the fibroid datarecord item comprises a fibroid size.

5. The system of Example 4, wherein the fibroid size comprises one of:

-   -   small;    -   medium; or    -   large.

6. The system of any one of Examples 1-5, wherein the fibroid datarecord item comprises a fibroid treatment status.

7. The system of any one of Examples 1-6, wherein the fibroid datarecord item comprises a fibroid treatment order.

8. The system of any one of Examples 1-7, wherein the processor isfurther programmed to receive user input.

9. The system of Example 8, wherein the user input comprises at leastone of:

-   -   user fibroid data record items; or    -   treatment data record items.

10. The system of Example 9, wherein the processor is programmed, inresponse to the user input, to:

-   -   update the one or more data sources with the user fibroid data        record item; and    -   update the user interface data such that the interactive user        interface includes an indication of at least one of the user        fibroid data record items.

11. The system of any one of Examples 8-10, wherein the user inputincludes export criteria comprising at least one of:

-   -   an export content;    -   an export format; or    -   an export location.

12. The system of Example 11, wherein the processor is programmed, inresponse to the user input, to:

-   -   extract, from the fibroid data records, fibroid data export        items relating to the export content;    -   generate an export document comprising the export format and the        fibroid data export items;    -   store the export document at the export location; and    -   update the user interface data such that the interactive user        interface includes an indication of the export request.

13. The system of any one of Examples 1-12, wherein the interactive userinterface further comprises a legend.

14. The system of any one of Examples 1-13, wherein the visualrepresentation comprises a fibroid icon.

15. The system of Example 14, wherein the visual representation isconfigured to indicate a warning to the user.

16. The system of any one of Examples 1-15, wherein the processor isprogrammed to:

-   -   identify a fibroid using a information from an imaging modality;    -   receive fibroid data from the imaging modality; and    -   generate an exploratory report.

17. The system of any one of Examples 1-16, wherein the processor isprogrammed to:

-   -   receive fibroid data from a one or more data sources;    -   generate user interface data for rendering an interactive user        interface on an electronic display, the interactive user        interface including:    -   an interactive fibroid map, and    -   a visual representation of a fibroid data record item, the        visual representation comprising a marker on the interactive        fibroid map at a respective fibroid location associated with the        fibroid data item, the visual representation configured to        provide information relating to the fibroid data record item;    -   receive treatment data from a treatment device; and    -   update the user interface with treatment data.

18. The system of Example 17, wherein the program further programmed togenerate a treatment report.

19. A system comprising:

-   -   a non-transitory computer readable storage medium configured to        store program instructions; and    -   a processor programmed to execute the program instructions to        cause the processor to:    -   identify a fibroid using a information from an imaging modality;    -   receive fibroid data from the imaging modality; and    -   generate a user interface data for rendering an interactive user        interface on an electronic display, the interactive user        interface including:    -   an interactive fibroid map, and    -   a visual representation of a fibroid data record item, the        visual representation comprising a marker on the interactive        fibroid map at a respective fibroid location associated with the        fibroid data item, the visual representation configured to        provide information relating to the fibroid data record item.

20. The system of Example 19, further comprising the imaging modality,wherein the imaging modality comprises an ultrasound transducer.

21. The system of any one of Examples 19-20, wherein the programinstructions further cause the processor to generate an exploratoryreport.

22. A system comprising:

-   -   a non-transitory computer readable storage medium configured to        store program instructions; and    -   a processor programmed to execute the program instructions to        cause the processor to:    -   receive fibroid data from a one or more data sources;    -   generate user interface data for rendering an interactive user        interface on an electronic display, the interactive user        interface including:    -   an interactive fibroid map, and    -   a visual representation of a fibroid data record item, the        visual representation comprising a marker on the interactive        fibroid map at a respective fibroid location associated with the        fibroid data item, the visual representation configured to        provide information relating to the fibroid data record item;    -   receive treatment data from a treatment device; and    -   update the user interface with treatment data.

23. The system of Example 22, wherein the program further programmed togenerate a treatment report.

24. The system of any one of Examples 22-23, further comprising animaging modality, wherein the imaging modality comprises an ultrasoundtransducer.

25. The system of any one of Examples 22-24, further comprising anablation device, wherein the ablation device comprises an radiofrequencygenerator.

26. A method of providing a system for treating a fibroid, the methodcomprising:

-   -   providing a system comprising a processor programmed to execute        the program instructions to cause the processor to:    -   receive fibroid data;    -   generate user interface data for rendering an interactive user        interface on an electronic display;    -   receive treatment data from a treatment device; and    -   update the user interface with treatment data; and    -   instructing a user to input fibroid data.

27. The method of Embodiment 26 further comprising instructing a user todetermine a fibroid treatment order.

28. The method of any of Examples 26-27, wherein the interactive userinterface includes:

-   -   an interactive fibroid map, and    -   a visual representation of a fibroid data record item, the        visual representation comprising a marker on the interactive        fibroid map at a respective fibroid location associated with the        fibroid data item, the visual representation configured to        provide information relating to the fibroid data record item.

29. A system comprising:

-   -   a non-transitory computer readable storage medium configured to        store program instructions;    -   an imaging modality configured to transmit information; and    -   a processor programmed to execute the program instructions to        cause the processor to:    -   receive the information from the imaging modality; and    -   generate a user interface data for rendering an interactive user        interface on an electronic display, the interactive user        interface including:    -   a fibroid map, and    -   a visual representation of a fibroid data record item, the        visual representation comprising a marker on the interactive        fibroid map at a respective fibroid location associated with the        fibroid data item, the visual representation configured to        provide knowledge relating to the fibroid data record item.

30. The system of Example 29, wherein the information comprises at leastone of a position of the imaging modality, an orientation of theimagining modality, an insertion depth, an insertion angle, a fibroidlocation, and a fibroid size.

31. The system of any one of Examples 29-30, wherein the imagingmodality comprises a sensor configured to determine at least one of aposition and an orientation of the imagining modality.

32. The system of Example 31, wherein the information comprisesinformation representative of at least one of position and orientationof the imaging modality.

33. The system of any one of Examples 31-32, wherein the sensorcomprises at least one of an optical tracking system, inertial sensors,and visual markers.

34. The system of any one of Examples 31-33, wherein the imagingmodality further comprises an alignment marker configured to emit asignal comprising information representative of at least one of positionand orientation of the imaging modality.

35. The system of Example 34, further comprising a receiver configuredto receive the signal emitted by the alignment marker.

36. The system of any one of Examples 34-35, wherein the alignmentmarker comprises a source of electromagnetic radiation.

37. The system of any one of Examples 29-36, further comprising anablation tool.

38. The system of Example 37, wherein the ablation tool is coupled tothe imaging modality.

39. The system of any one of Examples 29-38, further comprising atracking system configured to at least partially determine at least oneof position, orientation, and motion of the imaging modality.

40. The system of any one of Examples 29-39, wherein the processor isconfigured to generate the interactive user interface using theinformation received from the imaging modality.

41. The system of any one of Examples 29-40, wherein the visualrepresentation is configured to overlay the interactive fibroid map.

VIII. Additional Examples

Each of the processes, methods, and algorithms described in thepreceding sections may be embodied in, and fully or partially automatedby, code modules stored in memory and executed by one or more computersystems or computer processors comprising computer hardware. Theprocesses and algorithms may be implemented partially or wholly inapplication-specific circuitry.

The various features and processes described above may be usedindependently of one another, or may be combined in various ways. Allpossible combinations and subcombinations are intended to fall withinthe scope of this disclosure. In addition, certain method or processblocks may be omitted in some implementations. The methods and processesdescribed herein are not limited to any particular sequence, and theblocks or states relating thereto can be performed in other sequencesthat are appropriate. For example, described blocks or states may beperformed in an order other than that specifically disclosed, ormultiple blocks or states may be combined in a single block or state.The example blocks or states may be performed in serial, in parallel, orin some other manner. Blocks or states may be added to or removed fromthe disclosed example embodiments. The example systems and componentsdescribed herein may be configured differently than described. Forexample, elements may be added to, removed from, or rearranged comparedto the disclosed example embodiments.

Conditional language, such as, among others, “can,” “could,” “might,” or“may,” unless specifically stated otherwise, or otherwise understoodwithin the context as used, is generally intended to convey that certainembodiments include, while other embodiments do not include, certainfeatures, elements and/or steps. Thus, such conditional language is notgenerally intended to imply that features, elements and/or steps are inany way required for one or more embodiments or that one or moreembodiments necessarily include logic for deciding, with or without userinput or prompting, whether these features, elements and/or steps areincluded or are to be performed in any particular embodiment.

The term “comprising” as used herein should be given an inclusive ratherthan exclusive interpretation. For example, a general purpose computercomprising one or more processors should not be interpreted as excludingother computer components, and may possibly include such components asnon-transitory memory, input/output devices, and/or network interfaces,among others. Also, the term “or” is used in its inclusive sense (andnot in its exclusive sense) so that when used, for example, to connect alist of elements, the term “or” means one, some, or all of the elementsin the list. In addition, the articles “a,” “an,” and “the” as used inthis application and the appended claims are to be construed to mean“one or more” or “at least one” unless specified otherwise.

As used herein, a phrase referring to “at least one of” a list of itemsrefers to any combination of those items, including single members. Asan example, “at least one of: A, B, or C” is intended to cover: A, B, C,A and B, A and C, B and C, and A, B, and C. Conjunctive language such asthe phrase “at least one of X, Y and Z,” unless specifically statedotherwise, is otherwise understood with the context as used in generalto convey that an item, term, etc. may be at least one of X, Y or Z.Thus, such conjunctive language is not generally intended to imply thatcertain embodiments require at least one of X, at least one of Y and atleast one of Z to each be present.

The processes, methods, and systems may be implemented in a network (ordistributed) computing environment. Network environments includeenterprise-wide computer networks, intranets, local area networks (LAN),wide area networks (WAN), personal area networks (PAN), cloud computingnetworks, crowd-sourced computing networks, the Internet, and the WorldWide Web. The network may be a wired or a wireless network or any othertype of communication network.

Any process descriptions, elements, or blocks in the flow diagramsdescribed herein and/or depicted in the attached figures should beunderstood as potentially representing modules, segments, or portions ofcode which include one or more executable instructions for implementingspecific logical functions or steps in the process. Alternateimplementations are included within the scope of the embodimentsdescribed herein in which elements or functions may be deleted, executedout of order from that shown or discussed, including substantiallyconcurrently or in reverse order, depending on the functionalityinvolved, as would be understood by those skilled in the art.

Code modules or any type of data may be stored on any type ofnon-transitory computer-readable medium, such as physical computerstorage including hard drives, solid state memory, random access memory(RAM), read only memory (ROM), optical disc, volatile or non-volatilestorage, combinations of the same and/or the like. The methods andmodules (or data) may also be transmitted as generated data signals(e.g., as part of a carrier wave or other analog or digital propagatedsignal) on a variety of computer-readable transmission mediums,including wireless-based and wired/cable-based mediums, and may take avariety of forms (e.g., as part of a single or multiplexed analogsignal, or as multiple discrete digital packets or frames). The resultsof the disclosed processes or process steps may be stored, persistentlyor otherwise, in any type of non-transitory, tangible computer storageor may be communicated via a computer-readable transmission medium.

The ranges disclosed herein also encompass any and all overlap,sub-ranges, and combinations thereof. Language such as “up to,” “atleast,” “greater than,” “less than,” “between,” and the like includesthe number recited. Numbers preceded by a term such as “about” or“approximately” include the recited numbers and should be interpretedbased on the circumstances (e.g., as accurate as reasonably possibleunder the circumstances, for example ±5%, ±10%, ±15%, etc.). Forexample, “about 1” includes “1.” Phrases preceded by a term such as“substantially,” “generally,” and the like include the recited phraseand should be interpreted based on the circumstances (e.g., as much asreasonably possible under the circumstances). For example,“substantially spherical” includes “spherical.” Unless stated otherwise,all measurements are at standard conditions including temperature andpressure.

It should be emphasized that many variations and modifications may bemade to the above-described embodiments, the elements of which are to beunderstood as being among other acceptable examples. All suchmodifications and variations are intended to be included herein withinthe scope of this disclosure. The foregoing description details certainembodiments of the invention. It will be appreciated, however, that nomatter how detailed the foregoing appears in text, the invention can bepracticed in many ways. As is stated above, it should be noted that theuse of particular terminology when describing certain features oraspects of the invention should not be taken to imply that theterminology is being re-defined herein to be restricted to including anyspecific characteristics of the features or aspects of the inventionwith which that terminology is associated. The scope of the inventionshould be construed in accordance with the appended claims and anyequivalents thereof.

1. A system comprising: a non-transitory computer readable storage medium configured to store program instructions; and a processor programmed to execute the program instructions to cause the processor to: aggregate, from one or more data sources, a plurality of fibroid data records; extract, from the plurality of fibroid data records, fibroid data record items; and generate user interface data for rendering an interactive user interface on an electronic display, the interactive user interface including: an interactive fibroid map, and a visual representation of a fibroid data record item, the visual representation comprising a marker on the interactive fibroid map at a respective fibroid location associated with the fibroid data item, the visual representation configured to provide information relating to the fibroid data record item.
 2. The system of claim 1, wherein the processor is further programmed to automatically populate the interactive fibroid map with the visual representation of the fibroid data record item.
 3. The system of claim 1, wherein the respective fibroid location of the marker comprises a graphical representation of a fibroid location in a uterus of a patient.
 4. The system of claim 1, wherein the processor is programmed to aggregate a plurality of fibroid data records from at least one of: an input from a user; a user data source; or a third party data source.
 5. The system of claim 1, wherein the fibroid data record item comprises at least one of a fibroid location, a fibroid type, a fibroid size, a fibroid treatment status, a number of fibroids, and a fibroid treatment order.
 6. The system of claim 1, wherein the fibroid data record item comprises a fibroid type, and wherein the fibroid type comprises one of intramural, submucosal, subserosal, pedunculated submucosal and pedunculated subserosal.
 7. The system of claim 1, wherein the fibroid data record item comprises a fibroid treatment status.
 8. The system of claim 1, wherein the fibroid data record item comprises a fibroid treatment order.
 9. The system of claim 1, wherein the processor is further programmed to receive user input.
 10. The system of claim 9, wherein the user input comprises at least one of: user fibroid data record items; or treatment data record items.
 11. The system of claim 10, wherein the processor is programmed, in response to the user input, to: update the one or more data sources with the user fibroid data record item; and update the user interface data such that the interactive user interface includes an indication of at least one of the user fibroid data record items.
 12. The system of claim 9, wherein the processor is programmed, in response to the user input, to permit a user to manually populate the interactive fibroid map with the visual representation of the fibroid data record item.
 13. The system of claim 9, wherein the user input includes export criteria comprising at least one of: an export content; an export format; or an export location.
 14. The system of claim 13, wherein the processor is programmed, in response to the user input, to: extract, from the fibroid data records, fibroid data export items relating to the export content; generate an export document comprising the export format and the fibroid data export items; store the export document at the export location; and update the user interface data such that the interactive user interface includes an indication of the export request.
 15. The system of claim 1, wherein the interactive user interface further comprises a legend.
 16. The system of claim 1, wherein the visual representation comprises a fibroid icon.
 17. The system of claim 16, wherein the visual representation is configured to indicate a warning to the user.
 18. The system of claim 1, wherein the processor is programmed to: identify a fibroid using an information from an imaging modality; receive fibroid data from the imaging modality; and generate an exploratory report.
 19. The system of claim 1, wherein the processor is programmed to: receive fibroid data from a one or more data sources; generate user interface data for rendering an interactive user interface on an electronic display, the interactive user interface including: an interactive fibroid map, and a visual representation of a fibroid data record item, the visual representation comprising a marker on the interactive fibroid map at a respective fibroid location associated with the fibroid data item, the visual representation configured to provide information relating to the fibroid data record item; receive treatment data from a treatment device; and update the user interface with treatment data.
 20. The system of claim 19, wherein the program further programmed to generate a treatment report. 